Cancers that are reported by Dr. Bihari to apparently respond to LDN:
Bladder Cancer
Breast Cancer
Carcinoid
Colon & Rectal Cancer
Glioblastoma
Liver Cancer
Lung Cancer (Non-Small Cell)
Lymphocytic Leukemia (chronic)
Lymphoma (Hodgkin's and Non-Hodgkin's) Malignant Melanoma
Multiple Myeloma
Neuroblastoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer (untreated)
Renal Cell Carcinoma
Throat Cancer
Uterine Cancer > What the Future Holds
If the results of trials of low dose naltrexone in certain cancers are positive, the drug could eventually become an additional mainstay of cancer treatment ? adjunctive with chemotherapy, radiation, and other cancer cell growth inhibitor receptor agonists ? or even a replacement for current therapies, as primary treatment for those cancers that show little response to standard therapies.
No comments:
Post a Comment